NASDAQ : GDTC

CytoMed Therapeutics Limited — Earnings Estimates

$0.99 USD

$0.11 (12.5%)

Volume
22.68K
Average Volume
18.89K
Market Capitalization
$11.71M
P/E Ratio
-3.16
Dividend Yield
0.00%
Price Target
Year High
$3.68
Year Low
$0.68
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$5.17

Annual earnings financials

GDTC financial data with annual/quarterly toggle

GDTC GAAP EPS - Annual & Quarterly

GDTC Sales Revenue - Annual & Quarterly

GDTC Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

GDTC Estimated and Actual Revenue by Quarter
GDTC Estimated and Actual EPS by Quarter
GDTC Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-06-30 1 -99540 -99540 -99540 -99540 -99540 -99540
2025-03-31 1 -105.04K -105.04K -105.04K -105.04K -105.04K -105.04K
2024-06-30 1 -126.86K -126.86K -126.86K -126.86K -126.86K -126.86K
2024-03-30 1 -93600 -93600 -93600 -93600 -93600 -93600
GDTC Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-06-30 1 -601.77K -601.77K -601.77K 873.4K 873.4K 873.4K
2025-03-31 1 -635.01K -635.01K -635.01K 921.64K 921.64K 921.64K
2024-06-30 1 -479.32K -479.32K -479.32K 1.39M 1.39M 1.39M
2024-03-30 1 -354.28K -354.28K -354.28K 1.07M 1.07M 1.07M
GDTC Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-06-30 1 165.9K 165.9K 165.9K 1 -0.0510464 -0.0510464 -0.0510464
2025-03-31 1 175.06K 175.06K 175.06K 1 -0.0538656 -0.0538656 -0.0538656
2024-06-30 1 211.43K 211.43K 211.43K 1 -0.040659 -0.040659 -0.040659
2024-03-30 1 156K 156K 156K 1 -0.03 -0.03 -0.03